We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
(+11%)
Cap. Flow
-$707M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$99.9M |
| 2 |
Uber
UBER
|
+$71M |
| 3 |
Broadcom
AVGO
|
+$36.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$32.6M |
| 5 |
lululemon athletica
LULU
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$139M |
| 2 |
Apple
AAPL
|
+$72.7M |
| 3 |
VMW
VMware, Inc
VMW
|
+$47.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$42.3M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$35.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Financials | 13% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MURA
3126
DELISTED
Mural Oncology
MURA
| $142K | ﹤0.01% |
+23,999
| New | +$96.5K |
|
3127
CGI
GIB
$15.5B
| $142K | ﹤0.01% |
1,320
-50
| -4% | -$5.07K |
|
3128
Atour Lifestyle Holdings
ATAT
$4.8B
| $141K | ﹤0.01% |
8,145
-6,465
| -44% | -$117K |
|
|
MPX
3129
DELISTED
Marine Products Corp
MPX
| $141K | ﹤0.01% |
12,386
-196
| -2% | -$2.21K |
|
|
ORGN
3130
DELISTED
Origin Materials
ORGN
| $139K | ﹤0.01% |
5,541
+58
| +1% | +$1.66K |
|
3131
Bilibili
BILI
$7.84B
| $139K | ﹤0.01% |
11,390
+235
| +2% | +$3.07K |
|
|
KYNB
3132
Kyntra Bio
KYNB
$29.4M
| $137K | ﹤0.01% |
6,183
| – | – |
|
|
DNMR
3133
DELISTED
Danimer Scientific, Inc.
DNMR
| $137K | ﹤0.01% |
3,355
+39
| +1% | +$2.12K |
|
3134
Babcock & Wilcox
BW
$1.39B
| $136K | ﹤0.01% |
93,357
-1,068
| -1% | -$2.27K |
|
|
AV
3135
DELISTED
Aviva Plc
AV
| $136K | ﹤0.01% |
12,395
| – | – |
|
3136
Design Therapeutics
DSGN
$876M
| $135K | ﹤0.01% |
50,864
-1,612
| -3% | -$3.69K |
|
3137
X4 Pharmaceuticals
XFOR
$460M
| $135K | ﹤0.01% |
5,346
| – | – |
|
3138
Agnico Eagle Mines
AEM
$90.5B
| $134K | ﹤0.01% |
2,447
-59
| -2% | -$2.95K |
|
3139
ICL Group
ICL
$6.85B
| $133K | ﹤0.01% |
26,575
| – | – |
|
3140
Kaltura
KLTR
$267M
| $133K | ﹤0.01% |
68,029
-1,373
| -2% | -$2.42K |
|
3141
XPeng
XPEV
$11.6B
| $133K | ﹤0.01% |
9,085
+80
| +0.9% | +$1.27K |
|
3142
Protalix BioTherapeutics
PLX
$198M
| $131K | ﹤0.01% |
73,686
-21,717
| -23% | -$33.8K |
|
|
MOND
3143
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $131K | ﹤0.01% |
47,286
-729
| -2% | -$2.6K |
|
3144
AirSculpt Technologies
AIRS
$353M
| $130K | ﹤0.01% |
17,366
+152
| +0.9% | +$963 |
|
3145
Hippo Holdings
HIPO
$861M
| $130K | ﹤0.01% |
14,207
+229
| +2% | +$1.9K |
|
3146
Larimar Therapeutics
LRMR
$432M
| $129K | ﹤0.01% |
28,322
-614
| -2% | -$2.07K |
|
3147
Harmony Gold Mining
HMY
$12.3B
| $129K | ﹤0.01% |
20,942
-3,610
| -15% | -$19K |
|
3148
KVH Industries
KVHI
$157M
| $128K | ﹤0.01% |
24,301
+200
| +0.8% | +$977 |
|
|
MAGN
3149
Magnera Corp
MAGN
$460M
| $128K | ﹤0.01% |
5,057
+48
| +1% | +$1.01K |
|
3150
Criteo S.A. Ordinary Shares
CRTO
$923M
| $126K | ﹤0.01% |
4,977
| – | – |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
- RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
- RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
- RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.